{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.1",
    "document_metadata": {
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "king2015",
      "version": "1.0.0",
      "authors": "Rana Aldisi",
      "description": "This file encodes the article Identification and Characterization of a G Protein-binding Cluster in alpha7 Nicotinic Acetylcholine Receptors by King et. al, 2015"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/cf4d8bb88754f036b943b4d94ad96e103dcb7149/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
      "PUBCHEM": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/hbp-knowledge/hbp_knowledge/king2015.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "calcium(2+)",
      "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "choline",
      "id": "88fb57fa667be5fcf348ed86cb041de48401b10103512c286ebe600483744af962b0f34c7d2f8cfb57af6f72aaab29d8787cb64de2aa5d58ecd6fe01876d0cee"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "nifedipine",
      "id": "696c65b67cde0b7a3464047b24f9a4bfa3573b94e8d56556cf3cec506a61b0119301672412e3b59b27175862945ca0dab7b47c9a9671c1391a54532ad95ea4ba"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "alpha-Bungarotoxin",
      "id": "02171b540a693de054b64ff6294b0fea1a718756451334d44b4e7b35f1d50a130c69ab67d990047cf7155235514fe3919dbd72bd3d2975df8091bdc9bdaeb39e"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Calcium Channels",
      "id": "717197b61b759ef2be3144c29f03429113fd927dd475a37f66ab129f4ec169f72cd116e4d75aed0c7c7dfb71a6702a0e1bfb1155246f50ffff060565ace36ff0"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "GP Antagonist-2A peptide",
      "id": "fe34e0694989111558546fce9b061b76c0f53def07cfbd528b348047d32737788fc43f29bd56f7f82ffb895badc54b939385c7d470f837a69dd189d1736b5f33"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "xestospongin C",
      "id": "86c7e4c14b2002000a2cfe57b47dbc3a0e9afc3f5fc2706bb303d3e863078864c7e9cd44ebecbf68051f764b2fdb02850731afcdc10b0b0c26ea2d870eeabf74"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Barium",
      "id": "0b92cb4228b7b7e51da33e586ca366aea8943b0a0c35899a9a28fe673504c185d3b312fef1bb2b75e3c10c3dee02341f9cdf288208ad25fb860d21e4369d9ac7"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "calcium-mediated signaling",
      "id": "e52c3fa7d781bbd2fc7d349f637ecca12da54363ef2265c6029aa095261ed8b7e4d17070486a3570a0cc4d773d2caa11307593b50e6558294b9df79542acce86"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "nAChR assembly",
      "id": "672cf3002c3dce0eea87be341553669337f623de2e033ff7997f01d5b7d5043e6a6c4af9675734af5754631fe6ae064c658511d29f997f8109181bdb52cf105d"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Pleckstrin Homology Domains",
      "id": "e25a3e92936e96fbe7272ef98c6bdad914979756b7dec4cddf5b1c691e008dced27a6a75cfc93a83d555d6153212769dce01b716c9e5772e8d08a75b003d7125"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "HBP",
          "name": "alpha-Bungarotoxin",
          "id": "02171b540a693de054b64ff6294b0fea1a718756451334d44b4e7b35f1d50a130c69ab67d990047cf7155235514fe3919dbd72bd3d2975df8091bdc9bdaeb39e"
        },
        {
          "function": "Protein",
          "namespace": "MESH",
          "name": "Heterotrimeric GTP-Binding Proteins",
          "id": "5af452eda74893dd9c24a73391162db794b27aea9f4b858e81fb176a430ece9f290c03ba3a87eb7f88f0e1c8f618fa9a992d6c288de163816ed45e73fac22b13"
        }
      ],
      "id": "3638447d6048dd34762b101439d3bf4de755d0f4f9b1aa297b53512751cf242000fe07d544ce00fce61e35acbfaa1e891c288cdcae71138db4d20b00c723a0d1"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "G_beta",
          "id": "8a8a66caea8723b2cb80da44b823f6cbeae116a39e4fad4c9e41204bebb1e5ba61ba65fe867fe746d0c7fdf6c324148dd060f1c2fabdebc0980ac21efab619a0"
        },
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "G_gamma",
          "id": "d1950a4ee23b1f35682ca025e31e9a5d570eb85c9433c64f8eefead9661cfc0eb2b183bdf4ae721250e1e5e750e85924ca4198048a77c6dca041f0707236f054"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        }
      ],
      "id": "5e7647faa61f91fec49d830f1f7c8eaff8860322d93837877cbe8002ffe7172a1ed984e5ec460b6a4e8a5b3073bec50d3a5ef64e4cd411580381022b4a8a5fa3"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "G_beta",
          "id": "8a8a66caea8723b2cb80da44b823f6cbeae116a39e4fad4c9e41204bebb1e5ba61ba65fe867fe746d0c7fdf6c324148dd060f1c2fabdebc0980ac21efab619a0"
        },
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "G_gamma",
          "id": "d1950a4ee23b1f35682ca025e31e9a5d570eb85c9433c64f8eefead9661cfc0eb2b183bdf4ae721250e1e5e750e85924ca4198048a77c6dca041f0707236f054"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "variants": [
            {
              "kind": "hgvs",
              "identifier": "p.345A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.346A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.347A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.348A"
            }
          ],
          "id": "137858d12db8b5ca223a051702289ae6de2860491591dde9fbc8609029e847ae7efe4ae5d02ec102736537f1cb351532aadd0ebeab22b731be13068ed4c0d9d1"
        }
      ],
      "id": "0df936104c5d51948c4154cf4d5ec3ce1321446af5e298071c71ac686d4a112d4964b72f8f0391f451240a5d54068e0315f6e9b3d0bc6fc17d9542dd48f7636d"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "G_protein",
          "id": "a9e0ddc6aecbfb75f850b86f363f0e60dbc525c49092429fd0c85d60a92b31be4b3409fd70559a21b127cb65544060ebdd457d0e33d786e4fd446ee62416f90a"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        }
      ],
      "id": "43c72b65957104b30bbea4b012af3bd902e8b2e341239fb4d52999193f0ecfd873d8f8844ad78791cd60109f5c942aeab68f87190fdd1b58e5141d860e033078"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GNAI1",
          "id": "1514ea33e47015bebf4a589921ae3d57bc8d1a2b5754ac9b32fb524e390edf382876062cddbac380420ebbe05231aef1fb72a71c6d7821c8632a91a284de88a7"
        }
      ],
      "id": "d5506f3f15355d66d58e570a81daf5dff35358d2bce69f9481a4869e6a887ec00062fd7dbd6ef9a28f360e89f282bc40ce60c4030f445b05f414b88aaae424b5"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GNAI2",
          "id": "affd61adc43cec3728c887e87258bef8164f97d3d007b3c49ddfe1ac7807614dc7d2a98277fd3970c8b48fc42b23539d8c89e1f141c47b84e09a987e55262f78"
        }
      ],
      "id": "02cc822710feeff7a39a546dee52198573e9ab467298ded6f30cbbe6c507efb8761f1f38782a6ee9310cc57af4d6b26cf869478361f7abf05ca58ab33c450b6c"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GNAQ",
          "id": "b7fb28864f3be796cef96e3a77a1d483207b6a92b42926882862b04499675e6ef3a8140ba46c7327432474b6ea391e216d36dbce4fba566786a0e07119b727b4"
        }
      ],
      "id": "975a85ef83ed68423c625ad4a976755baed7fd27b93285cc98da1ea68c8d527f98b9d6c4553661a5dfa0838092ad1f8bd34f62c9a7d5ff7073cd9b1cafbe6c56"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GNAS",
          "id": "f277af488812753c4516beaaae584461e8ff327b7e233679599fee21d613f04387d20ffe2a7d0ce1512aeec929d5a5bfeb574935f506af9be43032c27e9b90d1"
        }
      ],
      "id": "2d3972fca324357b01a6456ad426e7f3196b82017f6d74360eec990bd663d6d1d54686e2700808182333f3a13e982d6bb916b312dd76ec560c9bbed52febd72d"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        },
        {
          "function": "Protein",
          "namespace": "HGNCGENEFAMILY",
          "name": "G protein subunits beta",
          "id": "8090be4e9c19bb1b34bbc79a8d36d60f552a4cd32279160d7eb008e6a593acf0b8f500af965b534fee08aec3633e3d92c3f922246272d2e8b68d05a0083f923d"
        }
      ],
      "id": "8a66805c9e5c4a7bce489af81fe4801a688e7f19fb4923c96a37aa324dea88fcf21419e9af2ef01d2be39da0cad2a2fc69f3492b6e29e52d454b027f75fbf170"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "variants": [
            {
              "kind": "hgvs",
              "identifier": "p.345A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.346A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.347A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.348A"
            }
          ],
          "id": "137858d12db8b5ca223a051702289ae6de2860491591dde9fbc8609029e847ae7efe4ae5d02ec102736537f1cb351532aadd0ebeab22b731be13068ed4c0d9d1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GNAQ",
          "id": "b7fb28864f3be796cef96e3a77a1d483207b6a92b42926882862b04499675e6ef3a8140ba46c7327432474b6ea391e216d36dbce4fba566786a0e07119b727b4"
        }
      ],
      "id": "b26b3eb37a6af14feab47ce19b1ba5aee97caac40e5d68ec85183beaa236b20ba382b555e8b9ff0b5b848b09cfe957cf0d08fc6dae4a12d2c2572f0e5cec62e9"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "choline",
          "id": "88fb57fa667be5fcf348ed86cb041de48401b10103512c286ebe600483744af962b0f34c7d2f8cfb57af6f72aaab29d8787cb64de2aa5d58ecd6fe01876d0cee"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        }
      ],
      "id": "7cecc7edac27af9589593233b49d1b8dffdf5bf7abb9c0eeb662fcd8b438e0fcd7b1277f3c42e0cb2406721e7d25d5e470e72990ed7a388732c46ebec36f64db"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "choline",
          "id": "88fb57fa667be5fcf348ed86cb041de48401b10103512c286ebe600483744af962b0f34c7d2f8cfb57af6f72aaab29d8787cb64de2aa5d58ecd6fe01876d0cee"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "variants": [
            {
              "kind": "hgvs",
              "identifier": "p.345A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.346A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.347A"
            },
            {
              "kind": "hgvs",
              "identifier": "p.348A"
            }
          ],
          "id": "137858d12db8b5ca223a051702289ae6de2860491591dde9fbc8609029e847ae7efe4ae5d02ec102736537f1cb351532aadd0ebeab22b731be13068ed4c0d9d1"
        }
      ],
      "id": "0602cf02c939c5602b69df67fbe539326c04386409e3dff2dce30e2e1f3b707db91919df27cc018bf5f7e203a512954119e88b1779b9844eb12c5321eb7e7fe5"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Protein",
          "namespace": "HBP",
          "name": "alpha-Bungarotoxin",
          "id": "9e4c8fe98acb3ccf42c18e9674a254c31f39f57da44b30dcdf7efb269c15cfb0afa1a10a7e4325eb81934dcd3f4d01de30e6fec24dcad0320c8b88dfc4904b0f"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CHRNA7",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
        },
        {
          "function": "Protein",
          "namespace": "MESH",
          "name": "Heterotrimeric GTP-Binding Proteins",
          "id": "5af452eda74893dd9c24a73391162db794b27aea9f4b858e81fb176a430ece9f290c03ba3a87eb7f88f0e1c8f618fa9a992d6c288de163816ed45e73fac22b13"
        }
      ],
      "id": "2a8e14afc3b61f92919de97b3a6b563f019585f06545b7ba61cb0e62765af67eb01df38aa36dcfb10fbb461538ba8fdbc6925980a58ac7fe5056c37c95b80484"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "CHRNA7",
      "id": "7cedf3fb9592a88354fbd6d9fc15df0242cfc3887d67f446c7cb34a86e24d256425157c0eb28ffb4446552048e1b4f289d6ce3b01454d8b9737c020fe3243523"
    },
    {
      "function": "Gene",
      "namespace": "HGNC",
      "name": "CHRNA7",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.345A"
        },
        {
          "kind": "hgvs",
          "identifier": "p.346A"
        },
        {
          "kind": "hgvs",
          "identifier": "p.347A"
        },
        {
          "kind": "hgvs",
          "identifier": "p.348A"
        }
      ],
      "id": "06c432396313598fd96438ef2e76adb2a0978f662223f6ec84c99e00418e6ec87e9e1878f981324a2b707bf5f1dbf764e16ffa18705fde52e632ea17dd492364"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "G_beta",
      "id": "8a8a66caea8723b2cb80da44b823f6cbeae116a39e4fad4c9e41204bebb1e5ba61ba65fe867fe746d0c7fdf6c324148dd060f1c2fabdebc0980ac21efab619a0"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "G_gamma",
      "id": "d1950a4ee23b1f35682ca025e31e9a5d570eb85c9433c64f8eefead9661cfc0eb2b183bdf4ae721250e1e5e750e85924ca4198048a77c6dca041f0707236f054"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "G_protein",
      "id": "a9e0ddc6aecbfb75f850b86f363f0e60dbc525c49092429fd0c85d60a92b31be4b3409fd70559a21b127cb65544060ebdd457d0e33d786e4fd446ee62416f90a"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "GPBC, Glycine Receptor 1",
      "id": "8850a58fd17e935ad04760fe3248b1d070b4d7431295a3cb28a2f1c556fc7b1c67b6005d64b127f2ad8de970db53b581b6844c11d7bf7ef51a2fc79760bc32bb"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "GPBC, alpha-7 nAChR",
      "id": "c71b13149e12f3f9e65b1fe90b22e0f7f229b33d80efed2428eecfc284597774ac58609e97b58cdf2f5c555180d373a8584f14b0d979799d3f6ef5a0aa9f824b"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "alpha-Bungarotoxin",
      "id": "9e4c8fe98acb3ccf42c18e9674a254c31f39f57da44b30dcdf7efb269c15cfb0afa1a10a7e4325eb81934dcd3f4d01de30e6fec24dcad0320c8b88dfc4904b0f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CHRNA7",
      "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CHRNA7",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.345A"
        },
        {
          "kind": "hgvs",
          "identifier": "p.346A"
        },
        {
          "kind": "hgvs",
          "identifier": "p.347A"
        },
        {
          "kind": "hgvs",
          "identifier": "p.348A"
        }
      ],
      "id": "137858d12db8b5ca223a051702289ae6de2860491591dde9fbc8609029e847ae7efe4ae5d02ec102736537f1cb351532aadd0ebeab22b731be13068ed4c0d9d1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GNAI1",
      "id": "1514ea33e47015bebf4a589921ae3d57bc8d1a2b5754ac9b32fb524e390edf382876062cddbac380420ebbe05231aef1fb72a71c6d7821c8632a91a284de88a7"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GNAI2",
      "id": "affd61adc43cec3728c887e87258bef8164f97d3d007b3c49ddfe1ac7807614dc7d2a98277fd3970c8b48fc42b23539d8c89e1f141c47b84e09a987e55262f78"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GNAQ",
      "id": "b7fb28864f3be796cef96e3a77a1d483207b6a92b42926882862b04499675e6ef3a8140ba46c7327432474b6ea391e216d36dbce4fba566786a0e07119b727b4"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GNAS",
      "id": "f277af488812753c4516beaaae584461e8ff327b7e233679599fee21d613f04387d20ffe2a7d0ce1512aeec929d5a5bfeb574935f506af9be43032c27e9b90d1"
    },
    {
      "function": "Protein",
      "namespace": "HGNCGENEFAMILY",
      "name": "G protein subunits beta",
      "id": "8090be4e9c19bb1b34bbc79a8d36d60f552a4cd32279160d7eb008e6a593acf0b8f500af965b534fee08aec3633e3d92c3f922246272d2e8b68d05a0083f923d"
    },
    {
      "function": "Protein",
      "namespace": "MESH",
      "name": "Heterotrimeric GTP-Binding Proteins",
      "id": "5af452eda74893dd9c24a73391162db794b27aea9f4b858e81fb176a430ece9f290c03ba3a87eb7f88f0e1c8f618fa9a992d6c288de163816ed45e73fac22b13"
    }
  ],
  "links": [
    {
      "line": 89,
      "relation": "increases",
      "evidence": "As shown in Fig. 1A, α7 nAChRs were found in association with Gαs, Gαq, and Gαi proteins within the hippocampus and prefrontal cortex. Striatal fractions suggest α7 interaction with Gαq and Gαi subunits (Fig. 1A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Prefrontal Cortex": true,
          "Hippocampus": true
        }
      },
      "source": 37,
      "target": 18,
      "key": "d2db1295d4b99e50476c3723a74f7253c2a2fbb480d92de8753a987060fd1f558c8960c726294f5bd6225acf7e11d0f25d7b6c949e20306faa796a7ec7ab74c0"
    },
    {
      "relation": "hasComponent",
      "source": 18,
      "target": 32,
      "key": "09552804fdfcff588b941c024936c8e3d28533d0bde3f22071b82dcd6821cee826bc5b2b8a585c1dbc6c2420e8fbe4d9bd0a088793225489b626c27b06e72600"
    },
    {
      "relation": "hasComponent",
      "source": 18,
      "target": 37,
      "key": "4d6820c75440586f042bb4dd0f586ec27d02c7e7f3eea41b6ec091017d0e4941f66f7dfb606bfc4f9513bf071c3f71b18093a341a058aeac1d88fc4ee1bc77e4"
    },
    {
      "line": 135,
      "relation": "increases",
      "evidence": "The findings confirm that the mutation in α7345–348A does not interfere with the trafficking or expression of the nAChR.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 32,
      "target": 9,
      "key": "58b4c9a43f021a1e2d5c942ca41827693d39b875e9c48c4fba8c26b3a009bde7bf74422dfb5954c08f02804b6bcf945b479bf05b12fef9e963c9e3312f156b3d"
    },
    {
      "relation": "hasVariant",
      "source": 32,
      "target": 33,
      "key": "05799e5d6439c16f62d58440b54e0c032f4bbeffa679be41a2aa7334f83e8e3783276210c0bff48119427ab58e04654bf56b60d5e142dd3d857b0419959076e6"
    },
    {
      "line": 147,
      "relation": "increases",
      "evidence": "Western blot analysis confirms that transfection of α7 nAChRs augments total α7 subunit expression in PC12 cells, which express endogenous α7 nAChRs. Transfection with α7 (α7+) increased the immunoreactive α7 signal by over 60% from endogenous mock-transfected control cells, whereas transfection with the mutant α7345–348A increased the total α7 signal by 48% over the endogenous α7 from control cells (Fig. 3A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "source": 32,
      "target": 32,
      "key": "7a72131b5807f06445be9cbf004d907b7ff80c1db7db8d33c1c78c79e39e08f72e62b95425d0784dc3d9ac66aa8f3a9605a83357e9c16b12d0060439d91df605"
    },
    {
      "line": 176,
      "relation": "increases",
      "evidence": "An increase in G protein association within the α7 complex was observed in α7+ cells (Gαq +16.71%; Gβγ +19.90%) (Fig. 3A). Similar findings in transfected N2a cells indicate a loss in G protein association within the α7 complex when α7345–348A nAChRs are expressed (Fig. 3B). ",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 32,
      "target": 17,
      "key": "1c92fa03886e901c55ae865dbb74261efa37cc841e7edf016acecdca12ee6dfb6806e09d92424057957f042f0923213b29f62700d7c7504a819ad9ab1a132b55"
    },
    {
      "line": 177,
      "relation": "increases",
      "evidence": "An increase in G protein association within the α7 complex was observed in α7+ cells (Gαq +16.71%; Gβγ +19.90%) (Fig. 3A). Similar findings in transfected N2a cells indicate a loss in G protein association within the α7 complex when α7345–348A nAChRs are expressed (Fig. 3B). ",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 32,
      "target": 12,
      "key": "6e915d94ceb631b1f10854b3eedb6bcbdd0acb38d16ba2d0ef77c7897a103b493aae7f5df4ac6ec7e2e0150aee844b17ef2a91b240c08faa261d6928081e7b63"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "As shown in Fig. 1A, α7 nAChRs were found in association with Gαs, Gαq, and Gαi proteins within the hippocampus and prefrontal cortex. Striatal fractions suggest α7 interaction with Gαq and Gαi subunits (Fig. 1A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Prefrontal Cortex": true,
          "Hippocampus": true
        }
      },
      "source": 36,
      "target": 17,
      "key": "308ffa2867b939bfcfa8f4314269ce028e48844449ca12f83d33eb4baaa60b720661bb363a61b32c8a286f23f77603051f8307a3cb3bb85b0673f4f42148208b"
    },
    {
      "relation": "hasComponent",
      "source": 17,
      "target": 32,
      "key": "2a76eb96595f7f76140ef0f871b62544e77aab50935888ba663ba56e17701bf7e4c5c99639576640b26dd30c7f0c22d8dff698458937fbb7407d252277ee5f3c"
    },
    {
      "relation": "hasComponent",
      "source": 17,
      "target": 36,
      "key": "acaded21539026aa94ed2192259cea290164a5f6f4c0b465422b54b7e4ad4f1038586581082ecde2b64200bbe3820536a80c285ca0019f40d87e3e048508a5f4"
    },
    {
      "line": 91,
      "relation": "increases",
      "evidence": "As shown in Fig. 1A, α7 nAChRs were found in association with Gαs, Gαq, and Gαi proteins within the hippocampus and prefrontal cortex. Striatal fractions suggest α7 interaction with Gαq and Gαi subunits (Fig. 1A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Prefrontal Cortex": true,
          "Hippocampus": true
        }
      },
      "source": 34,
      "target": 15,
      "key": "9147e778072be9e4e3b8b337dec75e9e5e247d4aeaa3584e325bf37091bb8e6d65b4bae2ddccdeb68c9548ba956e7601877c0fbd778371517bc93763f5ecfa25"
    },
    {
      "relation": "hasComponent",
      "source": 15,
      "target": 32,
      "key": "52061af6d90ed47eaf360ecaf4b5771487d657b2fc74864d1acd8f628273bc3707cfeae994f5ab801566d656fa6c0556e93b4dfd185afb912f9f31333888e0e6"
    },
    {
      "relation": "hasComponent",
      "source": 15,
      "target": 34,
      "key": "cb4e43b285f750ca70b37c5c2191a0cd19e610d98a4a4f48c2e6352993a7d283d6ec894d510e9e6899a38fb827db2d0ae4368583da49d32a5912b417d674abfb"
    },
    {
      "line": 92,
      "relation": "increases",
      "evidence": "As shown in Fig. 1A, α7 nAChRs were found in association with Gαs, Gαq, and Gαi proteins within the hippocampus and prefrontal cortex. Striatal fractions suggest α7 interaction with Gαq and Gαi subunits (Fig. 1A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Prefrontal Cortex": true,
          "Hippocampus": true
        }
      },
      "source": 35,
      "target": 16,
      "key": "6a1b03aab7cd4844db775881862ead70bf1de92c5e8bb35063caef209e8bded077655e91724ea1693d87967cae6647dfcecce872286022323c2fd8db13d8f288"
    },
    {
      "relation": "hasComponent",
      "source": 16,
      "target": 32,
      "key": "1f10ab25dc7e812e976c7bb4ebd9cf6e7b34845912de63067b8759276a5cb1619c9078000bcfc9931f1149cd922301cc353f7a27752af1d5245d590da6dad85e"
    },
    {
      "relation": "hasComponent",
      "source": 16,
      "target": 35,
      "key": "328bbba498764c9cdb24ab1d115c9f1550de7bf463b680895df2029121cf387f3bd93fd8d966d54aa8eb74c264642a715168b1001a01bee84417623f89e85299"
    },
    {
      "line": 110,
      "relation": "increases",
      "evidence": "An association between α7 nAChRs and Gβ was observed in the prefrontal cortex and hippocampus, whereas little to no detection of Gαo was seen in the adult brain (Fig. 1A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Prefrontal Cortex": true,
          "Hippocampus": true
        }
      },
      "source": 38,
      "target": 14,
      "key": "f8f47bfa9298c0f4c6cd7f8135ab2bf78d90ac26e4d35f86bb2f3c0767a5cde07a95dd4aebe515eb0f405c45fa10a0980db090731eb5189b274c3dabc92b14d3"
    },
    {
      "relation": "hasComponent",
      "source": 14,
      "target": 28,
      "key": "0377579be2f42d93203fee3e07e5a7649fb7acc663145770366232736c9d4ff8b488c69dabd79e906490e9ad99c258eba66730c2fbd02fff0dfcf0a9361901e5"
    },
    {
      "relation": "hasComponent",
      "source": 14,
      "target": 32,
      "key": "dcf408de428e8683b8235f118bd694685f6a3f69d22e9b05a11d60526f29b53e4983b9394dc1a9b7a5860da0434dddf3c0b15591109cdd086b0f3a5b2d07b09f"
    },
    {
      "relation": "hasComponent",
      "source": 23,
      "target": 31,
      "key": "8fbb63694ddd8ef9359fd3e055f8a9902001892303a1ebf21877840776884f53d28beae0a947eafb46fca455cfb4f17f35dd41e3ef56f9c63245379c79b65653"
    },
    {
      "relation": "hasComponent",
      "source": 23,
      "target": 32,
      "key": "c94c32283c0384de13e60a88d2bd9243fb5fd2f501c2f15ca64726f37feb1324d27f6129130108d09194fc543ee42e76a84285be14f7a24022b0d25573990eb5"
    },
    {
      "relation": "hasComponent",
      "source": 23,
      "target": 39,
      "key": "afc213b4701c0888bfc7a256336b21d52d35af6e12061ba105dd00af8994d264469cb4e07082f81d209c8d5c440a277ed20cb797f6ce09f4abf83791d2e1162c"
    },
    {
      "line": 121,
      "relation": "increases",
      "evidence": "Gel lanes of the BgtxC were divided into 3 molecular mass fractions: F1, 190-90 kDa; F2, 89-45 kDa; and F3, 44-15 kDa (Fig. 1C). Proteomic analysis was performed on the individual fractions using tryptic in-gel digestion followed by high-performance LC-ESI. A cohort of G proteins was identified in the F2 and F3 fractions (Fig. 1D). These G proteins were not detected in BgtxC from α7−/− mice (data not shown).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 23,
      "target": 11,
      "key": "66dfdc0470900deaf517fdd72fd82f9bfac84fdd0becf746a1109205d170c9da6eb54abcb3fa670d242b21e41498d3120eae3720d69a7514b4c1bfb096bd2e37"
    },
    {
      "relation": "hasComponent",
      "source": 11,
      "target": 3,
      "key": "2c53ae6a967fe720924dc9b3ad1f2c829f4d258afde6967d84f15dd444ec761f162232019a1d9f4b1e72ac7dd08cb899f81d80ac1a5fa8ec3d7c4e3073bab42f"
    },
    {
      "relation": "hasComponent",
      "source": 11,
      "target": 39,
      "key": "860e47c95d0ffe8efcf014c88cbb0c2975d42c14ab5320a3380d19571226b24af10840f0827b0f5ef3cb48a76c8ffaffedb4d2bcefda745ea37aaaae2262747a"
    },
    {
      "line": 129,
      "relation": "orthologous",
      "evidence": "Sequence alignment of mammalian nAChRs revealed a conservation of residues at the GPBC site in the M3-M4 loop (Fig. 2A). Based on amino acid similarity we found that α7 nAChRs possess 88% homology with the GyR1 at the GPBC (Fig. 2A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 30,
      "target": 29,
      "key": "48377da79f5ceb52d5a0b22ec7b66f5a8980d23dae61519f68a386fca9d6e29995d8f83367fc2cc1018e1bfc34712bad2e9e7053619f4b1c2653ff5e1caf50be"
    },
    {
      "line": 129,
      "relation": "orthologous",
      "evidence": "Sequence alignment of mammalian nAChRs revealed a conservation of residues at the GPBC site in the M3-M4 loop (Fig. 2A). Based on amino acid similarity we found that α7 nAChRs possess 88% homology with the GyR1 at the GPBC (Fig. 2A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 29,
      "target": 30,
      "key": "332a7f4aabf41ec8ab386bce479f19b167fd11a2e1bea4c7e68ab8a9435980f005ba3afec374add7601b9c7d349d8c9cbbf6a3e8c26cf35b4cc79b67e1c9e6df"
    },
    {
      "line": 136,
      "relation": "increases",
      "evidence": "The findings confirm that the mutation in α7345–348A does not interfere with the trafficking or expression of the nAChR.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 9,
      "key": "b944ae0db9ebc21a076d4c882a3d46a44fa64ed1963ce5a760b4d154d744fc166ed066babea0a5e87e5cb6782a3780791981b7f068e00fb3e7b841e0f5db6ecb"
    },
    {
      "line": 148,
      "relation": "increases",
      "evidence": "Western blot analysis confirms that transfection of α7 nAChRs augments total α7 subunit expression in PC12 cells, which express endogenous α7 nAChRs. Transfection with α7 (α7+) increased the immunoreactive α7 signal by over 60% from endogenous mock-transfected control cells, whereas transfection with the mutant α7345–348A increased the total α7 signal by 48% over the endogenous α7 from control cells (Fig. 3A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "source": 33,
      "target": 32,
      "key": "0a65e24c7fe23656482d270f96a2528787e846f3267faf0f4524a6888b99d44cc8eba429e24b8c51ecc1933c3a594ee23a72f0cbe2b6f65ef42a53b8366dd4e7"
    },
    {
      "line": 168,
      "relation": "directlyDecreases",
      "evidence": "As shown in Fig. 3A, coupling between Gαq and α7 nAChRs was virtually abolished by expression of α7345–348A. A noticeable loss in Gαq (−62.18%) and Gβγ (−20.03%) expression within the α7 nAChR complex IP was seen in cells transfected with α7345–348A (Fig. 3A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 20,
      "key": "2f4f82a2046e1095194d28428b31bee3e5953e3e2cc1ad36402ac5870076b95265c3f0d0a4b6f0ef575a35367c77def84f4dc6ddc2d022b4ffdec7cf37794d72"
    },
    {
      "line": 178,
      "relation": "directlyDecreases",
      "evidence": "An increase in G protein association within the α7 complex was observed in α7+ cells (Gαq +16.71%; Gβγ +19.90%) (Fig. 3A). Similar findings in transfected N2a cells indicate a loss in G protein association within the α7 complex when α7345–348A nAChRs are expressed (Fig. 3B). ",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 20,
      "key": "ff7fa7557e03cef290a14474790cdbea080d53458c85744d614bb825687f0e1e89529cb056084d74ca4b5eefebd1cd4ea2c9dcda0bef06bc9c495904fc49c908"
    },
    {
      "line": 185,
      "relation": "directlyDecreases",
      "evidence": "The data complements earlier findings on the ability of α7345–348A to function as a dominant negative blocker of G protein coupling in PC12 cells, and suggests that the GPBC directs nAChR association with Gαq and Gβγ.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 20,
      "key": "6a0b80f35d7580022aa51a683be7c6e99f9eeb1d0590856d3a74e9968ac0815170338852f2f17ec849cfdf41673af896c609302673c66ef1d9475a6e3fdc2008"
    },
    {
      "line": 255,
      "relation": "directlyDecreases",
      "evidence": "Because α7345–348A- transfected cells did not show any responsiveness to SP, these findings suggest this receptor mutant is not functionally coupled to Gαq.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 20,
      "key": "ccc8aae225f44a55510a9589d27eda3a59abf96dd4504755ef2a2f304f84bde1e810be752e573fec2828d1371c621e96eca8596ed0f5975ddc0e8137abdca764"
    },
    {
      "line": 169,
      "relation": "directlyDecreases",
      "evidence": "As shown in Fig. 3A, coupling between Gαq and α7 nAChRs was virtually abolished by expression of α7345–348A. A noticeable loss in Gαq (−62.18%) and Gβγ (−20.03%) expression within the α7 nAChR complex IP was seen in cells transfected with α7345–348A (Fig. 3A).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 13,
      "key": "e057d2bf30b1916af4b48b7a74b80814bb8c5637f44ac128777063fe0c098db243e9a5b5c20f66ddbf35a646701d6dbd25b423c0988a6b39555117635849fa17"
    },
    {
      "line": 179,
      "relation": "directlyDecreases",
      "evidence": "An increase in G protein association within the α7 complex was observed in α7+ cells (Gαq +16.71%; Gβγ +19.90%) (Fig. 3A). Similar findings in transfected N2a cells indicate a loss in G protein association within the α7 complex when α7345–348A nAChRs are expressed (Fig. 3B). ",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 13,
      "key": "d96c34be9e67ee8b7c4827e34315455160e88ba77998f73aed31e6819d6cfb5ad6943fb7997bc4deeb438a8b0ff4cc76e2305a976cf96321b090e646bb591144"
    },
    {
      "line": 186,
      "relation": "directlyDecreases",
      "evidence": "The data complements earlier findings on the ability of α7345–348A to function as a dominant negative blocker of G protein coupling in PC12 cells, and suggests that the GPBC directs nAChR association with Gαq and Gβγ.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 13,
      "key": "1b4c82067e721f26c545e6ff9507e9d62b2049b14e5adf13ebaf649ea157fb5c3a832fca4b1676f44c439be8aa62f457128fabc79d710220dd5d53697cef33c4"
    },
    {
      "line": 206,
      "relation": "decreases",
      "evidence": "PC12 cells transfected with α7345–348A showed a reduction in choline-mediated calcium responses.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 33,
      "target": 1,
      "key": "1189fed2f6b0408492a814738bf16c94028127c8cf9c4a7abe0f4b659a2ab9bee6eecc4324ccc0d5bf9ae6483e6321458900736e18fc627dc242f380b751732e"
    },
    {
      "line": 208,
      "relation": "decreases",
      "evidence": "PC12 cells transfected with α7345–348A showed a reduction in choline-mediated calcium responses.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "source": 33,
      "target": 0,
      "key": "a6c884e5f17c7efb30b1426bcb5de167a84160a4c282c562b745e4be7988500f028036d3255aeb6fa0d4ab5061a8bcd6bd8080f702ad20f35f4e9ce4d9a5a83b"
    },
    {
      "line": 357,
      "relation": "decreases",
      "evidence": "Xestospongin C treatment did not impact the calcium peak (628.87% ΔF/Fθ ± 69.43%) or total calcium transient (AUC: 443.86% ΔF/Fθ2 × s ± 54.72%; + xestospongin C = 340.39% ΔF/Fθ2 × s ± 96.99%) in α7345–348A expressing cells (α7 to α7 + xestospongin C, p = 0.017; α7 to α7345–348A, p = 0.013; α7 to α7345-348A + xestospongin C, p = 0.017) (Fig. 7, B and C). The data underscores the inability of α7345–348A nAChRs to activate intracellular calcium via IP3Rs (18).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "object": {
        "location": {
          "namespace": "GO",
          "name": "intracellular"
        },
        "modifier": "Activity"
      },
      "source": 33,
      "target": 0,
      "key": "f09916f887dfdb732aa2f01cd3424d4342789bc56fccf3b842081b20be38514a7bc88627e6c0571ed6b258a76c3e2d607a523b026a0e1b321806cc7d6d2bfb63"
    },
    {
      "line": 242,
      "relation": "decreases",
      "evidence": "These findings in N2a cells are consistent with data from PC12 cells and suggest that α7345–348A nAChR expression impairs nAChR calcium signaling.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 33,
      "target": 8,
      "key": "8164eb8e6c964af3416845cd650591112290a7bb981da4d5952ed14baa5c7f59783e3d745ae0748efe5edf6b09019a3c1568f3e76f0ea059709168ac9013558d"
    },
    {
      "line": 310,
      "relation": "decreases",
      "evidence": "In PC12 cells expressing α7345–348A nAChRs choline had a weak effect on PH-mCherry translocation relative to empty plasmid-transfected controls. Expression α7345–348A nAChRs was surprisingly associated with strong levels of PH-mCherry at the cell surface in the absence of drug treatment (Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cytosol": true,
          "PC12 Cells": true
        }
      },
      "source": 33,
      "target": 10,
      "key": "41aca936ad211dbbb8f1008eac395ea5c34884ef8bc570f6a8f67d2f095a87f08de1848139e43ab8acb1cb3a9810693e80f59a331f2ffc06228e2688de36998f"
    },
    {
      "line": 159,
      "relation": "causesNoChange",
      "evidence": "Studies in N2a cells indicate that transfection with α7345–348A yields a similar α7 nAChR expression as the wild-type (α7) and supports the finding that mutation at the GPBC does not impact the synthesis of the nAChR in cells.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true
        }
      },
      "source": 25,
      "target": 33,
      "key": "95b9d9263f2d3f40a0507357c158bf578fb88d906298755136a2e1b045d44c559936c2332f156c95318055989e1a6a1abcf9a3af2e6bef1de413df3904e1586f"
    },
    {
      "relation": "hasVariant",
      "source": 24,
      "target": 25,
      "key": "24710b673032cb558a1eff9e35cdcdbebf8bd32b7ccc67e37cbc06ba45a844513317396cd249b83f2f69dfa86699b9a2737e57b1e535c6ce0aa8c6a481ecb3c5"
    },
    {
      "relation": "hasComponent",
      "source": 20,
      "target": 33,
      "key": "fed11b9bcf7b31addf2663310bf7da86c218d7cc2bfe47d719e0ff4fe9fae20b5ef38f28880db4baa9b0eb67d3eabd327990ea3b883bb2591ccda8fada7ad6ea"
    },
    {
      "relation": "hasComponent",
      "source": 20,
      "target": 36,
      "key": "7f159083ba122f0ca239a2fe8993e022747ca37904a34a903643fa7f8322e392905fe9043f72a4ace0685ed78894a18e714ca967691d4de87296d2583f04e074"
    },
    {
      "relation": "hasComponent",
      "source": 13,
      "target": 26,
      "key": "f13b7e899a3ac9eda24965a62dbc21eef4ea84dbd18bbc2cd524c5a1cd7a8f78edf89cc57231ec8215c26b3cb6bf994985d6993e45595a3450afb6c0a01af967"
    },
    {
      "relation": "hasComponent",
      "source": 13,
      "target": 27,
      "key": "edb556e2a0232a2b3a6ffa32c31414e4cf78733cdede687943737ae2aa8684f2448042c1d92b3b7b576dee0b7bcf5d80b372ebb4fba5157b0f7b9bdd93386602"
    },
    {
      "relation": "hasComponent",
      "source": 13,
      "target": 33,
      "key": "ece1ce584f429aa4316af5064ea156159c3537e79f54b0a023864f6a9ca9984b59693f90faa4a0a26b9e2f6d61734ee1c0cd390d99ad588c9f5b378e95db49d8"
    },
    {
      "relation": "hasComponent",
      "source": 12,
      "target": 26,
      "key": "374cc6d0b8936fce525cc254f558dc49d2667824d68843265064ea52dac4b88613a42bffd5ecd3dae6dd0361f760a15832ea666e412878a25dbeedae07e7093c"
    },
    {
      "relation": "hasComponent",
      "source": 12,
      "target": 27,
      "key": "31590b48dd2c8c1039a7883a7379606f0d3523279245660c419e4ec3c2efb73644f84fcb943cd276d8c316f3e8497a5b5731b6ba65636f679a194deec35cfe83"
    },
    {
      "relation": "hasComponent",
      "source": 12,
      "target": 32,
      "key": "17adff6f50be1c04dc96c19b70501340e206176a0eb7a67bf1a84caecce90544547cb4b641c493d977b4fdac561535bd57a8ebe3c6efec0955bb646b0c155f37"
    },
    {
      "relation": "hasComponent",
      "source": 21,
      "target": 1,
      "key": "dfcb946ea6d24adb7f4851f1ff4e927c316243fd51ba9c478f17d30bfb5b0701397d0604ebc09d7952db5ee882bfb2156879b6472f9e9ccab41e40e782a6f49e"
    },
    {
      "relation": "hasComponent",
      "source": 21,
      "target": 32,
      "key": "8238a5506cfc45828939c39221ecb6210fcb5ce24ca368a59bee22c0d1525d45484ffac36f06a973e68820c4619da7ae6a1c3d1ff1c2f9481a2fb779b78949ef"
    },
    {
      "line": 197,
      "relation": "increases",
      "evidence": " In α7+ cells, choline application resulted in a calcium signal that peaked at 1050% ΔF/Fθ (±176.4%) in the neurite. Calcium transients in the GC were found to last for ∼1.6 s in both α7 and α7+ cells peaking at 1396% (±154.4%) and 1316% (±146.9%) ΔF/Fθ, relatively (Fig. 4, A and B).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurites": true
        }
      },
      "source": 21,
      "target": 0,
      "key": "dfd71ec90638a4c1cd3981d9cc194b2ae648e97fa161273c6d4aded8f95a06a604c2394fb54511c4960a07c68f112f836cf9bd20059f962f4cfe38fc782201ba"
    },
    {
      "line": 234,
      "relation": "increases",
      "evidence": "In N2a cells α7345–348A nAChR expression fostered a weak calcium response to (10 mM) choline, whereas expression of α7 nAChRs correlated with noticeable choline-induced calcium transient. Imaging studies in N2a cells expressing α7345–348A nAChRs indicate a significantly lowered calcium signal peak to choline (333.4% ΔF/Fθ ± 35.7%) when compared with N2a cells that express the α7nAChR (peak: 581% ΔF/Fθ ± 122.7%; p = 0.04) (Fig. 4, D and E).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true
        }
      },
      "source": 21,
      "target": 0,
      "key": "29bce7b08ba5bc010895075aea6d7f7c10a1ab9a7cc75eb52c45d3a3961d92f8cf586686560dff3a6dae3210c93b0deb6f4d41061c6fd1516b97e021c1c64b4c"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": "PC12 cells transfected with α7345–348A showed a reduction in choline-mediated calcium responses.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 1,
      "target": 0,
      "key": "56d528b4bdc8cb887fa68ec352d6f99707409d7e54f66a2e84a802f2b67a0aac471f404c904939c81331f06c3567676bba417b04e3fadad42adbf56dbfdde66c"
    },
    {
      "line": 287,
      "relation": "association",
      "evidence": "In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline-induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 1,
      "target": 4,
      "key": "1874552d36ce83c20275ca68b1caf76e3f04ec9377b2d7dd171643b2ac729d2bc18bd286d8d2d37e41304ae9863b67cb009486f41afe253c2e514a41eaa4ac13"
    },
    {
      "line": 298,
      "relation": "association",
      "evidence": "Treatment of PC12 cells with 10 mM choline was associated with a translocation of PH-mCherry from the cell surface as determined by the presence of the fluorescence signal within 1 μm of the edge of the cell into the cytosol of the GC (Fig. 6, A and B). Pre-treatment of cells with SP abolished this translocation (Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cytosol": true,
          "PC12 Cells": true
        }
      },
      "source": 1,
      "target": 10,
      "key": "2798c60c59ebf8a5700f38a71788abb4f330f17264fca5c47ba280e61e0b0a584951a642b8c2ef990c646ce1d481c4a5015334e5c7b5862c02aecc369aebbd74"
    },
    {
      "line": 327,
      "relation": "increases",
      "evidence": "Sequential imaging of PH-mCherry and GCaMP5G confirms that choline promotes a rise in intracellular calcium and PH-mCherry translocation in the same cellular compartment (Fig. 6, B and C). Cytoplasmic translocation of PH-mCherry occurred on a slower time scale (40 s after choline application) than peak calcium responses (∼1 s after choline application). These kinetics are consistent with the translocation of the PH domain sensor in the cell (20, 29).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cytosol": true
        }
      },
      "source": 1,
      "target": 10,
      "key": "b32248ee13d223d7dfc230603da3b4ef9c231ab849129e546b61f9dc49eb41bbb982d50ab0a3e5e3cf881ad03d4d02b6c0d9e9802b7556d11d57d2824fd220ac"
    },
    {
      "line": 364,
      "relation": "decreases",
      "evidence": "As shown in Fig. 8, A and B, IP of the α7 using the C-20 antibody suggests that choline application attenuates G protein binding with the nAChR. Choline treatment resulted in a 56% reduction in Gαq and 47% reduction in Gβ association within the α7 nAChR complex (Fig. 8B). ",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 1,
      "target": 14,
      "key": "500a3358404acf837dcf60516c0768497068068ecd20156983970c51cb331361f42b4f7177495d08d3a6c8b9cc05c272577360f0699e4f570d060b04a426db80"
    },
    {
      "line": 365,
      "relation": "decreases",
      "evidence": "As shown in Fig. 8, A and B, IP of the α7 using the C-20 antibody suggests that choline application attenuates G protein binding with the nAChR. Choline treatment resulted in a 56% reduction in Gαq and 47% reduction in Gβ association within the α7 nAChR complex (Fig. 8B). ",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 1,
      "target": 17,
      "key": "97cd2a99f689e62c98a267e91628ded109abad1e27fc281a405ba0f891ce2e0870cf80fd1e98dd53de7f0752739ae21e18eb25d1b74dce612491e6210f3ba042"
    },
    {
      "line": 366,
      "relation": "decreases",
      "evidence": "As shown in Fig. 8, A and B, IP of the α7 using the C-20 antibody suggests that choline application attenuates G protein binding with the nAChR. Choline treatment resulted in a 56% reduction in Gαq and 47% reduction in Gβ association within the α7 nAChR complex (Fig. 8B). ",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 1,
      "target": 19,
      "key": "e35cffa136b8a2c44d3baad7b6b14481566ab401c58d709e70c87f57d53ae7e54ed094a75cae9efccb72f6727619281acb9191b21ea17bbc34b4c7bf5ae8c67b"
    },
    {
      "line": 288,
      "relation": "association",
      "evidence": "In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline-induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 0,
      "target": 4,
      "key": "7a65903251f75dd9ff802032f6153b05dca5b9ab91e0e44f27b826a7d97afe6c941c0797aaac895e4c4e7c591b4527ea10dc1d95a5b69c7eb052d32d4d363fd7"
    },
    {
      "relation": "hasComponent",
      "source": 22,
      "target": 1,
      "key": "4fd71f215896178ac9272c144805a0281b8675e7a2fb45a430abe6f06f33f4f1662a6fd3bbfa228846c79c06693f32538562a42d7fea485746d3b1964b187c62"
    },
    {
      "relation": "hasComponent",
      "source": 22,
      "target": 33,
      "key": "4ebc255a26eab26f3acaa7a46d47467c60538bf9775ce1dbee9874a596faf5b59940c0d730867b5bc46807aec93aa1211392c0336724b78e333860c0516bdf17"
    },
    {
      "line": 221,
      "relation": "decreases",
      "evidence": "Most notably, in the GC, the calcium peak values were significantly lower in α7345–348A-transfected cells compared with α7 cells after Tukey's HSD post hoc comparisons (peak: 741 ± 159.8% ΔF/Fθ, p = 0.006). This represents a 46.92% reduction from the α7 baseline calcium response (Fig. 4, A and B). This reduction approached significance in the neurite of α7345–348A cells (peak: 561 ± 124.9% ΔF/Fθ) (Fig. 4, A and B)",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurites": true
        }
      },
      "source": 22,
      "target": 0,
      "key": "034d35e1460fe05a41a481f3fbe612028f61405cee868326f611b86620a24a83aaf12ada9193f13b04d66b5ce132c5847899c858c46deaf4f56c0781f0ba4a3f"
    },
    {
      "line": 235,
      "relation": "decreases",
      "evidence": "In N2a cells α7345–348A nAChR expression fostered a weak calcium response to (10 mM) choline, whereas expression of α7 nAChRs correlated with noticeable choline-induced calcium transient. Imaging studies in N2a cells expressing α7345–348A nAChRs indicate a significantly lowered calcium signal peak to choline (333.4% ΔF/Fθ ± 35.7%) when compared with N2a cells that express the α7nAChR (peak: 581% ΔF/Fθ ± 122.7%; p = 0.04) (Fig. 4, D and E).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true
        }
      },
      "source": 22,
      "target": 0,
      "key": "79c17d55256b22504bd9faa307a1dd81bd41501f78bf402319f0543e02d8ca226d971c36464b1fa9e3b320c7d7997f1a772f615a1bcda55fb1d1da422aa92387"
    },
    {
      "line": 248,
      "relation": "causesNoChange",
      "evidence": "SP pretreatment did not significantly alter calcium peaks in α7345–348A nAChR expressing cells, showing a small (−31.24%) reduction in calcium responses relative to the α7345–348A baseline measure (p > 0.05).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 5,
      "target": 0,
      "key": "2148da7ef343c5b3f928d2f9eaa52d68da93b8974f977f3e775e07bfb228b540f58c910a4581501f3297bead3b805bb83021cf0ab3372e8bdd304f568d3a3e83"
    },
    {
      "line": 249,
      "relation": "causesNoChange",
      "evidence": "SP pretreatment did not significantly alter calcium peaks in α7345–348A nAChR expressing cells, showing a small (−31.24%) reduction in calcium responses relative to the α7345–348A baseline measure (p > 0.05).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 5,
      "target": 33,
      "key": "3e10d1c7ca57d80a27baeecc9f74e355ff42328f491f9927164d6cd3d498884a4b9511e226ade8bf74588fe1482766d4ca535d2413240d7e85f1b45360bab4e2"
    },
    {
      "line": 299,
      "relation": "decreases",
      "evidence": "Treatment of PC12 cells with 10 mM choline was associated with a translocation of PH-mCherry from the cell surface as determined by the presence of the fluorescence signal within 1 μm of the edge of the cell into the cytosol of the GC (Fig. 6, A and B). Pre-treatment of cells with SP abolished this translocation (Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cytosol": true,
          "PC12 Cells": true
        }
      },
      "source": 5,
      "target": 10,
      "key": "07885aefaf90a49992c15222670ab0b719fb82c5f3fd53295c5cd16900f2bfcf74dd3e32116ae86bb478fe2d709f2cb7c34f0fc59f4c2eb2ade657252734dfd7"
    },
    {
      "line": 262,
      "relation": "causesNoChange",
      "evidence": "As shown in Fig. 5, A–C, barium replacement had little to no effect on the peak and total calcium transient observed in α7 (peak: 1474.83% ΔF/Fθ ± 162.00%; AUC: 693.5% ΔF/Fθ2 × s ± 154.15%) and α7345–348A expressing cells (peak: 794% ΔF/Fθ ± 81.36%; AUC: 543.5% ΔF/Fθ2 × s ± 89.59%).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 7,
      "target": 8,
      "key": "dc6be48e97e82c661e166794bf51baa4f0e0b9eccde920b7b90d35365b8e864e793edd6d37959b33f0141ca3bc38943aee3d24c843ea23ee60219ade1eab154d"
    },
    {
      "line": 263,
      "relation": "causesNoChange",
      "evidence": "As shown in Fig. 5, A–C, barium replacement had little to no effect on the peak and total calcium transient observed in α7 (peak: 1474.83% ΔF/Fθ ± 162.00%; AUC: 693.5% ΔF/Fθ2 × s ± 154.15%) and α7345–348A expressing cells (peak: 794% ΔF/Fθ ± 81.36%; AUC: 543.5% ΔF/Fθ2 × s ± 89.59%).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 33,
      "key": "9ace8ab4bd60e698545657136ecd5e30ee29263b9f9661cc932ddb07e84cb970895995334ec396a7fe05e4e1a8538692187b58a4eb25fe740d1f0a78c6f3afa6"
    },
    {
      "line": 264,
      "relation": "causesNoChange",
      "evidence": "As shown in Fig. 5, A–C, barium replacement had little to no effect on the peak and total calcium transient observed in α7 (peak: 1474.83% ΔF/Fθ ± 162.00%; AUC: 693.5% ΔF/Fθ2 × s ± 154.15%) and α7345–348A expressing cells (peak: 794% ΔF/Fθ ± 81.36%; AUC: 543.5% ΔF/Fθ2 × s ± 89.59%).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 32,
      "key": "968915568a287b0ad19d3e68dbdbf2e7a6ad4169b83f25bd65a8560723341a305ed63a02242853fa7ac4c5a5a0eba9e3886fe6e7f85a2819d2873ade1686b9bd"
    },
    {
      "line": 273,
      "relation": "decreases",
      "evidence": "As shown in Fig. 5, A–C, nifedipine was found to decrease the peak calcium response to choline in PC12 cells (peak: 795.00% ΔF/Fθ ± 107.1%) by 56.94% (p = 0.003), whereas prolonging the duration of the choline-induced calcium transient (AUC: 749.50% ΔF/Fθ2 × s ± 64.02%) in the same cell.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 1,
      "key": "e03347b49fe3cf29900d8184bb87b3fe862ae78caaab0807ada0ab39349440fc588d9aea81f2d820e8eed479c1c461e08468d3e7da8a55e475255c7006ed17d0"
    },
    {
      "line": 274,
      "relation": "decreases",
      "evidence": "As shown in Fig. 5, A–C, nifedipine was found to decrease the peak calcium response to choline in PC12 cells (peak: 795.00% ΔF/Fθ ± 107.1%) by 56.94% (p = 0.003), whereas prolonging the duration of the choline-induced calcium transient (AUC: 749.50% ΔF/Fθ2 × s ± 64.02%) in the same cell.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "source": 2,
      "target": 0,
      "key": "34b3cc7e3550ab0ed046ea815e7991a76b0b3f8495e2accef2261bd18729b8364a82e31a06e08d76584cf9d4b95dda15e9fab86d5680653b1796634300f295f1"
    },
    {
      "line": 275,
      "relation": "increases",
      "evidence": "As shown in Fig. 5, A–C, nifedipine was found to decrease the peak calcium response to choline in PC12 cells (peak: 795.00% ΔF/Fθ ± 107.1%) by 56.94% (p = 0.003), whereas prolonging the duration of the choline-induced calcium transient (AUC: 749.50% ΔF/Fθ2 × s ± 64.02%) in the same cell.",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "source": 2,
      "target": 8,
      "key": "26427f678dbb4043e32a53c7f08740a600dfdea925bdc3c6cb885f46cd068caa6775a5d68dcdc78ea998a1bf6e248268f1d442dd93f203b30c080cade245a279"
    },
    {
      "line": 286,
      "relation": "causesNoChange",
      "evidence": "In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline-induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "source": 2,
      "target": 8,
      "key": "85618cffc6fd417bfc13f6873e3d3f51287c8f3fe0af372c4016e1b03a870b3a42fa7e0ef25891be672771e23a96e717aef33757a30ce74ed18d30a539f57aba"
    },
    {
      "line": 285,
      "relation": "causesNoChange",
      "evidence": "In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline-induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 33,
      "key": "37c5b1abbfb4a0064917a0b79fc3c841bd2eba78c35c6eb4e6b8c2a0a614c98b63278df9dfc6101ebf6e2347d32d71a74ffb85d9fc9b9b45f7dd5f0fab935f19"
    },
    {
      "line": 287,
      "relation": "association",
      "evidence": "In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline-induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 1,
      "key": "57fc9c23a195315836ba8c2b4886b2ab19fba9d4cdc9422762dec1edb121f10c1563bf5787f513fdcbccad40ec6c76168d502d930c20046a09ba3310b3e9d760"
    },
    {
      "line": 288,
      "relation": "association",
      "evidence": "In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline-induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 0,
      "key": "ce7a282cb9cf7d4474c4825a06b3b30c89f84c3b7a750248a3e63d70ff382a029d00c90a32b896bf6cff521ea6c6bce45892ebf140d21f0956b34256bd21e2a4"
    },
    {
      "line": 298,
      "relation": "association",
      "evidence": "Treatment of PC12 cells with 10 mM choline was associated with a translocation of PH-mCherry from the cell surface as determined by the presence of the fluorescence signal within 1 μm of the edge of the cell into the cytosol of the GC (Fig. 6, A and B). Pre-treatment of cells with SP abolished this translocation (Fig. 6B).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cytosol": true,
          "PC12 Cells": true
        }
      },
      "source": 10,
      "target": 1,
      "key": "5731bda31e9d2a36f320c261b2c824ac3a68a40f30230d3ec63352c82dabda999dfd3cd06ed786dedced7c3efc9b0062f54755de9d554db024faed84b80f7d69"
    },
    {
      "line": 343,
      "relation": "decreases",
      "evidence": "We confirmed the involvement of IP3Rs in choline-induced calcium transients at the GC of PC12 cells. Cells were preincubated with the IP3R blocker xestospongin C (1 μM) prior to imaging. As shown in Fig. 7, A–C, pretreatment with xestospongin C reduced the α7 nAChR calcium response peak by 46.82% in α7 cells (peak: 1308.43% ΔF/Fθ ± −238.13%; + xestospongin C = 695.80% ΔF/Fθ ± 101.46%).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 6,
      "target": 32,
      "key": "986b45f771f9d9966f15c9b46b357ae5435508e04c28ebd6bf6971305d1b151ffc206066318ff3fb4ab7a067c15e950ee2174d337703c0a095a588e1d81b2438"
    },
    {
      "line": 344,
      "relation": "decreases",
      "evidence": "We confirmed the involvement of IP3Rs in choline-induced calcium transients at the GC of PC12 cells. Cells were preincubated with the IP3R blocker xestospongin C (1 μM) prior to imaging. As shown in Fig. 7, A–C, pretreatment with xestospongin C reduced the α7 nAChR calcium response peak by 46.82% in α7 cells (peak: 1308.43% ΔF/Fθ ± −238.13%; + xestospongin C = 695.80% ΔF/Fθ ± 101.46%).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "annotations": {
        "MeSHAnatomy": {
          "PC12 Cells": true
        }
      },
      "source": 6,
      "target": 8,
      "key": "a712e97128337dc043a45ef2a21041bb677fe901c2774eeb07f3389c276cee49961e956acd6b7ea059dbd027c1f58a0d5ac29758cc002e713bada22eb12c9642"
    },
    {
      "line": 356,
      "relation": "decreases",
      "evidence": "Xestospongin C treatment did not impact the calcium peak (628.87% ΔF/Fθ ± 69.43%) or total calcium transient (AUC: 443.86% ΔF/Fθ2 × s ± 54.72%; + xestospongin C = 340.39% ΔF/Fθ2 × s ± 96.99%) in α7345–348A expressing cells (α7 to α7 + xestospongin C, p = 0.017; α7 to α7345–348A, p = 0.013; α7 to α7345-348A + xestospongin C, p = 0.017) (Fig. 7, B and C). The data underscores the inability of α7345–348A nAChRs to activate intracellular calcium via IP3Rs (18).",
      "citation": {
        "type": "PubMed",
        "reference": "26088141"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 6,
      "target": 33,
      "key": "367c3fbcbec8946a4e3a6926d2173b312e8878e679818c6002d3872e036546c4c93ec23d71ee494d49a211a2998779a67b5146705efe68da332350814bf8aa0a"
    },
    {
      "relation": "hasComponent",
      "source": 19,
      "target": 32,
      "key": "6c267bb502b798a55709da96c5640691579e4d1d9d3c3e8bae0731686e5ff7bbf6b1212ef9211d999f7f25acd8ccb480ef3c3160c006bc45acb7a46f6c8213e9"
    },
    {
      "relation": "hasComponent",
      "source": 19,
      "target": 38,
      "key": "60f4cfa6819fa39e1ed5d77675e7503ed211ef0bed2d4a1da3af402ec813418ae50877c3aba2cd9d5bb49a136c93acd90e61687c1051f789bdcaaf0e5447813f"
    }
  ]
}